3rd Floor, Gateway Ekkamai Mall, Room 3128 (Next to GSBank)
0623789399
consultant@airmedclinic.com
Line OA : @airmedclinic
AirmedClinic.Bangkok

Airmed Clinic

Protect your kidney health—detect issues early before kidney failure strikes.
Welcome to Airmed Clinic

Chronic Kidney Disease – The Silent Threat to Life.
Our Services
Clinical research from Israel and other leading nations worldwide.
Research

Health tours thailand
"

Welcome to Airmed Clinic

(Thailand Curespec’s Partner)

Airmed Clinic (Thailand Curespec’s Partner) marks a major international medical collaboration with Curespec, low-energy Shockwave therapy for kidney care.

Now offering treatment in Thailand with certified rehabilitative medical.

Restoration therapy available and shockwave technology for patients with chronic kidney disease (CKD).

Research

Clinical studies and research on the Omnispec Model Vascuspec Type Low-Intensity Shockwave Therapy via eHAT Technology.

Research

Pre-Clinical Study Results

Tests conducted on mammals by Mayo Clinic demonstrated a clear improvement in capillary formation in the kidneys after treatment with the Low-Intensity Shockwave Therapy via eHAT Technology.

Mayo Clinic

Mayo Clinic is a globally renowned medical and research institution. As a non-profit organization, its mission is to advance medical and health research, foster innovation, and develop new treatments. With exceptional expertise in diagnosing and treating complex diseases, Mayo Clinic consistently ranks among the top medical institutions in the United States.

Source: Low-Energy Shockwave Therapy Improves Ischemic Kidney Microcirculation

Curespec conducted clinical research on stage 3–4 chronic kidney disease patients in collaboration with leading hospitals in Israel, Japan, and the Philippines. The studies yielded the following results.

Our Services

At Airmed Clinic, we provide kidney health treatments using Low-Intensity Shockwave Therapy via eHAT Technology. Care is delivered by medical rehabilitation specialists and is designed for individuals with chronic kidney disease (CKD) — without medication and without surgery. Each treatment course consists of 6 sessions, administered twice per week over 3 consecutive weeks, and supervised by experienced physicians. The full course fee is 360,000 THB.

Airmed Clinic is proud to support and enhance your kidney health journey.

Paibuljkiat Kheokao
Video
Oraphin Kanthiya
Video
Amnuay Bunthod
Video
Sanome Attaphong
55 years old.
"Now it doesn't hurt, and my back doesn't hurt anymore."

Video
Boonmee Khaochaimaha
79 years old.
"From heartbreak due to stage 4 kidney disease to hope at Airmed Clinic"
Video


Airmed Clinic is proud to be part of Thailand's health hub.


FAQ

1.What is the Omnispec Model Vascuspec Type Low-Intensity Shockwave Therapy via eHAT Technology and how does it help restore kidney function?

Omnispec Model Vascuspec Type Low-Intensity Shockwave Therapy via eHAT Technology is a low-intensity Shockwave Therapy (Li-ESWT) device using Electro-Hydraulic Acoustic Therapy (eHAT). It delivers shockwaves to both kidneys through the skin at 8 precise anatomical points, guided by ultrasound. These waves stimulate microvascular (capillary) growth in the kidneys, potentially improving kidney function depending on the patient’s condition.

No. The shockwaves target the kidneys externally. The procedure is safe, painless, non-invasive, requires no anesthesia, no medication, no surgery, no recovery period—and no dialysis. Each session takes under an hour.

Not recommended. This therapy focuses on preserving kidney function before dialysis becomes necessary.

Shockwave therapy is not recommended for individuals with transplanted kidneys.

If the patient is in Stage 5 but has not yet started dialysis, they may consider Omnispec Model Vascuspec Type Low-Intensity Shockwave Therapy via eHAT Technology treatment. While Stage 5 kidneys can no longer effectively filter waste, stimulating microvascular growth may delay the need for dialysis.

However, results vary per individual and shockwave therapy cannot replace dialysis. Research is still lacking on Stage 5-specific outcomes.

International studies show promising results. Upon completing the recommended program :
- Average reduction in blood pressure: 10–16 mmHg.
- Patients in stages 3–4 often maintain stable eGFR levels.
- Capillary growth improvement depends on individual response but trends positively.

Research suggests that six sessions over three weeks (one full course) can :
- Reduce both systolic and diastolic blood pressure in hypertensive kidney patients
- Stabilize kidney function as indicated by eGFR, sustained up to 12 months post-treatment
Yearly treatment is advised to prolong kidney function and postpone dialysis initiation.

Omnispec Model Vascuspec Type Low-Intensity Shockwave Therapy via eHAT Technology uses Electro-Hydraulic Acoustic Therapy (eHAT) with ultrasound guidance, targeting 8 specific areas of both kidneys. It focuses directly on the kidneys. The clinic only provides information on Omnispec Model Vascuspec Type Low-Intensity Shockwave Therapy via eHAT Technology and not other alternatives.

They both use shockwaves, but Low-Intensity Shockwave Therapy via eHAT TechnologyLow-Intensity Shockwave Therapy via eHAT Technology emits low-intensity waves tailored for kidney application, reaching deep renal tissue.

*Certified under CE standards (Europe), authorized for use across European countries.

One course consists of 6 sessions over 3 weeks. This may help stabilize kidney decline for up to one year.

Annual courses are recommended to maximize delay in kidney deterioration. Results vary per patient’s condition.

It’s the world’s first shockwave device developed specifically for kidney stimulation—a cutting-edge innovation. Research shows its potential in helping stage 3–4 kidney disease patients stabilize eGFR and reduce blood pressure.

The device is costly, and skilled operators—currently limited in Thailand—are required. That said, the price may decrease over time as demand rises.